Recent Updates
Recently added Catalysts
LNTH Negative Sentiment Score: 20/100

LANTHEUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Lantheus Holdings, Inc. on Behalf of Lantheus Stockholders and Encourages Investors to Contact the Firm

Key Takeaway: Bragar Eagel & Squire, P.C. is investigating Lantheus Holdings, Inc. on behalf of stockholders following the company's disappointing second quarter earnings report. On August 6, 2025, Lantheus announced a significant miss in both earnings-per-share and revenue, leading to a lowered full year guidance. This news prompted a steep decline in the company's stock price, dropping 28.58% on the same day. Investors who suffered losses are encouraged to contact the law firm to explore their legal options.

Market Sentiment Analysis

CONCERNS & RISKS

  • Lantheus reported disappointing second quarter 2025 results, missing earnings expectations.
  • The company lowered its full year revenue guidance significantly.
  • Lantheus's stock price fell by 28.58% on the news of their earnings report.
  • The company cited intensified pricing pressure and a strategic decision affecting volume sales.

Full Press Release Details

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Lantheus (LNTH) To Contact Him Directly To Discuss Their Options
If you purchased or acquired stock in Lantheus and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ:LNTH) on behalf of Lantheus stockholders. Our investigation concerns whether Lantheus has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On August 6, 2025, Lantheus announced disappointing second quarter 2025 results, revealing earnings-per-share ("EPS") and revenue figures that missed expectations. In addition, the Company lowered its full year 2025 revenue guidance from $1.550 billion - $1.585 billion to $1.475 billion - $1.51 billion and its full year 2025 adjusted fully diluted EPS guidance from $6.60 - $6.70 per share to $5.50 - $5.70 per share. During an earnings call held that same day, Lantheus's Chief Executive Officer cited intensified pricing pressure in the PSMA PET market and a conscious decision to walk away from volume at certain accounts to protect long-term franchise value. In addition, the Company's Chief Financial Officer stated that "consolidated net revenue for the second quarter was $378 million, a decrease of 4.1%. Radiopharmaceutical oncology currently PYLARIFY contributed $250.6 million of sales, down 8.3%, lower than previously expected."
On this news, Lantheus's stock price fell $20.76 per share, or 28.58%, to close at $51.87 per share on August 6, 2025.
If you purchased or otherwise acquired Lantheus shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form.  There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.

Tags

Bragar Eagel & Squire

Frequently Asked Questions

How can I contact Bragar Eagel & Squire regarding Lantheus?

You can reach out to Brandon Walker or Marion Passmore at (212) 355-4648.

What caused the drop in Lantheus's stock price?

Lantheus's stock fell after disappointing Q2 2025 results and lowering revenue guidance.

Who should I contact if I lost money investing in Lantheus?

Contact Brandon Walker or Marion Passmore to discuss your legal options.

What allegations is Bragar Eagel & Squire investigating?

The firm is investigating potential violations of federal securities laws by Lantheus.

Are there any costs to contacting Bragar Eagel & Squire?

There is no cost or obligation to discuss your case with the firm.

Last updated: Sep 8, 2025